Evidence map›Paper›PMID 41207937›Full record

ReviewAdvances in experimental medicine and biology2026

Protein Architecture and Composition in Mycobacterium tuberculosis.

Parissa Farnia, Ali Akbar Velayati, Jalaledin Ghanavi, Poopak Farnia

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parissa FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran. farnia@theaasm.org.
Ali Akbar VelayatiShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Jalaledin GhanaviShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Poopak FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protein architecture of Mycobacterium tuberculosis (Mtb) demonstrates remarkable complexity and adaptability, emblematic of its evolutionary refinement as a highly successful pathogen. The Mtb proteome can be broadly classified into four principal categories: core, accessory, transcriptionally plastic, and uncharacterized proteins. Core proteins are highly conserved across all Mtb strains and essential for fundamental cellular functions and bacterial viability; they form the structural and metabolic foundation required for critical processes such as DNA replication, transcription, and cell wall biosynthesis. Conversely, accessory proteins exhibit considerable variability among strains, endowing Mtb with strain-specific traits including virulence, environmental adaptation, and antibiotic resistance. These proteins are vital for enabling the pathogen to thrive in diverse ecological niches and to overcome selective pressures imposed by environmental factors and antimicrobial agents. Distinguished not by strain distribution but by regulatory dynamics, transcriptionally plastic proteins exhibit differential expression in response to environmental changes and host-derived cues, allowing Mtb to modulate its physiological state during infection rapidly. This regulatory flexibility supports the pathogen's ability to enter dormancy, mount stress responses, and transition between metabolic states. A substantial portion of the Mtb proteome remains uncharacterized or annotated as hypothetical, with functions yet to be elucidated. Nevertheless, recent advances in integrative bioinformatics and experimental proteomics have begun to clarify the roles of many such proteins, revealing novel contributions to bacterial survival, pathogenicity, and immune evasion. The complex interplay among these protein categories illustrates a highly sophisticated regulatory network that governs Mtb's growth, dormancy, stress adaptation, and persistence. This dynamic and adaptable protein architecture is fundamental to the bacterium's capacity to endure hostile host environments, evade immune surveillance, and establish chronic infections. Consequently, a comprehensive understanding of the composition, regulation, and functional plasticity of these protein classes is imperative. Such knowledge will drive the development of innovative diagnostics, next-generation vaccines, and targeted therapeutics, ultimately advancing more effective strategies for tuberculosis control and eradication.

Indexed as

Bacterial ProteinsMycobacterium tuberculosisProteomeGene Expression Regulation, BacterialHumansProteomicsTuberculosisBacterial ProteinsProteomeCell wallCore functional proteinsMolecular chaperonesMycobacterium tuberculosisTranscriptional plasticity proteinsUncharacterized proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.